Literature DB >> 19490747

Now you hear it, now you don't: vowel devoicing in Japanese infant-directed speech.

Laurel Fais1, Sachiyo Kajikawa, Shigeaki Amano, Janet F Werker.   

Abstract

In this work, we examine a context in which a conflict arises between two roles that infant-directed speech (IDS) plays: making language structure salient and modeling the adult form of a language. Vowel devoicing in fluent adult Japanese creates violations of the canonical Japanese consonant-vowel word structure pattern by systematically devoicing particular vowels, yielding surface consonant clusters. We measured vowel devoicing rates in a corpus of infant- and adult-directed Japanese speech, for both read and spontaneous speech, and found that the mothers in our study preserve the fluent adult form of the language and mask underlying phonological structure by devoicing vowels in infant-directed speech at virtually the same rates as those for adult-directed speech. The results highlight the complex interrelationships among the modifications to adult speech that comprise infant-directed speech, and that form the input from which infants begin to build the eventual mature form of their native language.

Entities:  

Mesh:

Year:  2009        PMID: 19490747     DOI: 10.1017/S0305000909009556

Source DB:  PubMed          Journal:  J Child Lang        ISSN: 0305-0009


  3 in total

1.  [Child-directed speech. Does it really help language acquisition?].

Authors:  S Meyer; M Jungheim; M Ptok
Journal:  HNO       Date:  2011-11       Impact factor: 1.284

Review 2.  [Prosody, speech input and language acquisition].

Authors:  M Jungheim; S Miller; D Kühn; M Ptok
Journal:  HNO       Date:  2014-04       Impact factor: 1.284

Review 3.  Motherese in interaction: at the cross-road of emotion and cognition? (A systematic review).

Authors:  Catherine Saint-Georges; Mohamed Chetouani; Raquel Cassel; Fabio Apicella; Ammar Mahdhaoui; Filippo Muratori; Marie-Christine Laznik; David Cohen
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.